(PQ) Drostanolone E 200

Drostanolone E 200

Manufacturer: Pharmaqo Labs

Category: Injection

Dose and Quantity: 200 mg/ml

Packaging: 10 ml vial

Form: Liquid

Active Substance: Drostanolone Enanthate

Active Half-Life: 4.5 to 5 days

Classification: AAS (Anabolic Androgenic Steroids)

Dosage: 300 to 700 mg per week

Water Retention: No

Aromatization: No

Information:

A lot of bodybuilders and athletes have been using this medicine called Drostanolone Enanthate produced by Pharmaqo to boost their performance and make them grow leaner muscles. This drug contains drostanolone enanthate which lasts for long once it has been injected into the body thereby ensuring that its effects are felt over an extended period of time.

Benefits for Bodybuilders:

Drostanolone Enanthate is famous for its ability to produce muscle tone and dry muscle. Drostanolone is often used for cutting cycles because it reduces water retention, increases vascularity which creates a more defined physique with lower body fat percentage. Also, due to its anti-estrogenic qualities this drug is preferred by some users valuing prevention of gynecomastia or water retention that occurs from excessive estrogen accumulation.

For people who use Drostanolone Enanthate, the results would be an increase in muscle strength and endurance, as well as increased muscle density. Other effects that have been documented include better athletic performance and speedier fat loss. Users who take drostanolone enanthate expect an increase in muscle strength and endurance as well as increased muscle density. Other documented effects include improved athletic performance and accelerated fat loss

Side Effects:

Any steroid usage has negative results including: Androgenic effects, cardiovascular troubles, suppression of testosterone, and damage of liver.

How to Use:

When providing intramuscular injections, it is recommended that men use anything between 400 and 600 mg per week. However, women should go for lower dosages at about 100-200mg per week in order to avoid virilization risks